U.S. Stock Movement Update: Agape ATP surges 87%, Oriental Culture plummets 79%, multiple stocks show significant movement

Market Overview of US Stocks in the Last Hour The US stock market has shown a significant sector rotation in the past hour, with technology and pharmaceutical stocks performing particularly well. Small-cap stocks and thematic stocks have experienced large fluctuations, with noticeable capital inflows. Market sentiment is relatively active, with short-term enthusiasm rising, and some individual stocks have shown significant price movements. The stock with the largest abnormal movement in the last hour is Agape ATP, which surged 87.35%, with trading volume significantly increasing and short-term capital inflows evident, leading to heightened market sentiment. Strong stocks include: 1. SMX Security Matters: up 67.70%, with a 10-day increase of 1113.76%, driven significantly by short-term capital. 2. Grande: up 59.08%, with a 5-day increase of 58.77%, gaining market attention. 3. HeartBeam: up 52.91%, with a 6-month increase of 51.28%, showing clear capital inflows. 4. Velo3D: up 38.26%, with increased trading volume and active short-term capital. 5. Mawson Infrastructure: up 37.54%, with increased trading volume and positive market sentiment. 6. Treasure Gbl: up 26.62%, with increased trading volume driven by short-term capital. 7. CapsoVision: up 25.59%, with increased trading volume and heightened market attention. 8. Nextdoor: up 25.34%, reaching a new 60-day high, with noticeable capital inflows

Shareholder Sangsangin Investment & Securities Co Ltd Sells 433,332 ($3.8M) Of Exicure Inc [XCUR]

Sangsangin Investment & Securities Co Ltd Shareholder of Exicure Inc [XCUR] filed a Form 4 on December 10, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:Date12/8/25TransactionSaleShares433,332Price$8.71Value$3,774,322Ending Holdings: 0 - DirectFor a free trial, or to learn more about our insider trading analysis and data services, please visit or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.

Exicure shares are trading higher after the company announced results from its completed Phase 2 trial evaluating burixafor combination with propranolol and granulocyte colony-stimulating factor for the mobilization of hematopoietic progenitor cells in patients with multiple myeloma undergoing autologous hematopoietic cell transplantation achieved its primary endpoint.

Exicure Reports Positive Phase 2 Results for Burixafor in Multiple Myeloma Stem Cell Mobilization

Exicure Inc. announced positive Phase 2 trial results for burixafor in multiple myeloma stem cell mobilization, achieving the primary endpoint in 90% of participants. The study showed favorable safety and rapid mobilization kinetics, with peak CD34+ cell levels within one hour of administration. Results were presented at the 2025 ASH Annual Meeting.

Exicure Inc. Announces Early Redemption of $3.1 Million Convertible Bonds to Simplify Capital Structure

Exicure Inc. announced the early redemption of $3.1 million in convertible bonds, originally due in 2028, to streamline its capital structure. The bonds were redeemed internally, funded through cash transfers, and are not expected to impact the company's financial statements materially. This move supports Exicure's biotechnology operations.